These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 22086872
1. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H. Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872 [Abstract] [Full Text] [Related]
2. Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H. Mol Carcinog; 2014 Apr; 53(4):314-24. PubMed ID: 23143693 [Abstract] [Full Text] [Related]
3. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells. Zheng Y, Izumi K, Yao JL, Miyamoto H. Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411 [Abstract] [Full Text] [Related]
4. Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice. Iida K, Mimura J, Itoh K, Ohyama C, Fujii-Kuriyama Y, Shimazui T, Akaza H, Yamamoto M. J Biochem; 2010 Mar; 147(3):353-60. PubMed ID: 19880377 [Abstract] [Full Text] [Related]
5. Promotion of bladder cancer development and progression by androgen receptor signals. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. J Natl Cancer Inst; 2007 Apr 04; 99(7):558-68. PubMed ID: 17406000 [Abstract] [Full Text] [Related]
6. Androgen activates β-catenin signaling in bladder cancer cells. Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, Miyamoto H. Endocr Relat Cancer; 2013 Jun 04; 20(3):293-304. PubMed ID: 23447569 [Abstract] [Full Text] [Related]
7. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth. Kawahara T, Ide H, Kashiwagi E, El-Shishtawy KA, Li Y, Reis LO, Zheng Y, Miyamoto H. Urol Oncol; 2016 Oct 04; 34(10):432.e15-23. PubMed ID: 27330033 [Abstract] [Full Text] [Related]
8. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Evangelou A, Jindal SK, Brown TJ, Letarte M. Cancer Res; 2000 Feb 15; 60(4):929-35. PubMed ID: 10706107 [Abstract] [Full Text] [Related]
9. Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer. Shiota M, Takeuchi A, Yokomizo A, Kashiwagi E, Tatsugami K, Kuroiwa K, Naito S. J Urol; 2012 Jul 15; 188(1):276-86. PubMed ID: 22608749 [Abstract] [Full Text] [Related]
10. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M. Cancer Res; 2004 Sep 15; 64(18):6424-31. PubMed ID: 15374950 [Abstract] [Full Text] [Related]
11. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors. Andrieu T, Bertolini R, Nichols SE, Setoud R, Frey FJ, Baker ME, Frey BM. Biochem Pharmacol; 2011 Dec 01; 82(11):1651-62. PubMed ID: 21907706 [Abstract] [Full Text] [Related]
12. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. Venken K, De Gendt K, Boonen S, Ophoff J, Bouillon R, Swinnen JV, Verhoeven G, Vanderschueren D. J Bone Miner Res; 2006 Apr 01; 21(4):576-85. PubMed ID: 16598378 [Abstract] [Full Text] [Related]
13. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression. Kawahara T, Shareef HK, Aljarah AK, Ide H, Li Y, Kashiwagi E, Netto GJ, Zheng Y, Miyamoto H. Oncotarget; 2015 Oct 06; 6(30):29860-76. PubMed ID: 26342199 [Abstract] [Full Text] [Related]
14. Neural androgen receptor regulation: effects of androgen and antiandrogen. Lu S, Simon NG, Wang Y, Hu S. J Neurobiol; 1999 Dec 06; 41(4):505-12. PubMed ID: 10590174 [Abstract] [Full Text] [Related]
15. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. BJU Int; 2012 Jun 06; 109(11):1716-26. PubMed ID: 22221549 [Abstract] [Full Text] [Related]
16. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Jie X, Lang C, Jian Q, Chaoqun L, Dehua Y, Yi S, Yanping J, Luokun X, Qiuping Z, Hui W, Feili G, Boquan J, Youxin J, Jinquan T. Oncogene; 2007 Aug 23; 26(39):5741-51. PubMed ID: 17369855 [Abstract] [Full Text] [Related]
17. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line. Hofbauer LC, Hicok KC, Khosla S. J Cell Biochem; 1998 Oct 01; 71(1):96-108. PubMed ID: 9736458 [Abstract] [Full Text] [Related]
18. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity. Wang LG, Liu XM, Kreis W, Budman DR. Biochem Biophys Res Commun; 1999 May 27; 259(1):21-8. PubMed ID: 10334909 [Abstract] [Full Text] [Related]
19. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. Hofbauer LC, Ten RM, Khosla S. J Bone Miner Res; 1999 Aug 27; 14(8):1330-7. PubMed ID: 10457265 [Abstract] [Full Text] [Related]
20. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Bao BY, Chuang BF, Wang Q, Sartor O, Balk SP, Brown M, Kantoff PW, Lee GS. Prostate; 2008 Jun 01; 68(8):839-48. PubMed ID: 18302198 [Abstract] [Full Text] [Related] Page: [Next] [New Search]